Issue link: https://uberflip.scri.com/i/1528368
47 SCRI Brand Identity Guidelines 3.0 2026 Table of Contents Patterns 2.5 These examples demonstrate how SCRI and Accelero maintain distinct visual identities while sharing common design principles. Pattern Family Full pattern Patients participating in treatment trials each year 3,100+ 40% Mint 0.75pt stroke 2 patterns stacked 4"x6" document size 40% Mint + Beam 0.75pt stroke 2 patterns stacked 4"x6" document size Today's clinical trials. Tomorrow's therapies. Today's clinical trials. Tomorrow's therapies. Photo with just outlined pattern Today's clinical trials. Tomorrow's therapies. Today's clinical trials. Tomorrow's therapies. Today's clinical trials. Tomorrow's therapies. White + filled in circle 1.5pt stroke 2 patterns stacked 1080x1080 px document size 2 patterns stacked 1080x1080 px document size 2 patterns stacked 1080x1080 px document size 2 patterns stacked 1080x1080 px document size White + Beam peek 1.5pt stroke 100% Mint + Beam container 1.5pt stroke White pattern 1.5pt stroke White pattern 1.5pt stroke 100% Mint pattern 1.5pt stroke 2 patterns stacked 1080x1080 px document size 2 patterns stacked 1080x1080 px document size Accelerco Brand Pattern SCRI Brand Pattern SCRI serves as the maestro of clinical trial delivery, orchestrating first-in-class services. Overview What is Accelero™? Accelero maximizes all parts of SCRI to accelerate drug development and optimize clinical trial delivery. Coordinated through our CRO, SCRI Development Innovations, Accelero enhances connectivity to SCRI research sites, which in turn maximizes site contributions, optimizes site activation timelines, and synchronizes end-to-end clinical research management. Why Accelero? The challenges faced by pharma partners in conducting clinical trials are multifaceted and intricate - including regulatory compliance, patient recruitment, and data management. The key to overcoming these hurdles lies in leveraging community oncology, as exemplified by SCRI. To meet the needs of pharma our sites, allowing them to operate at their highest potential. ensures optimal site performance and facilitates the seamless execution of clinical trials. What is EHR2EDC (E2E)? Through SCRI's Development Innovations Data Management team and integration with Genospace, Accelero works with Sponsors to seamlessly integrate data from the Electronic Health Record (EHR) to the Electronic Data Capture (EDC), EHR2EDC (E2E) systems for automation of clinical trial data collection. By removing the barrier of manual site data entry, E2E increases timely access to clinical trial data and improves the overall quality of the data. Automated E2E data does not need to be source data verified or cleaned through the traditional data delivery. Benefits What are the benefits of Accelero for sites? • consistent and teams can focus on higher value work • Time savings with less manual data entry and fewer queries generated • Consistent ways of working for more standardized study execution • Timely resolution of key issues with well defined escalation pathways. What are the benefits of Accelero for physicians? • Improved satisfaction in research processes • Increased access to trials and expanded trial menu What are the benefits of Accelero for Sponsors? • Improved US enrollment • Enhanced site performance • Increased patient access • Accelerated timelines to open sites • Improved data integrity through streamlined data delivery solutions What are the benefits of Accelero for SCRI? • priced at time and materials and toward value delivered by • Increased control of site selection and number of trial slots • Improved colleague satisfaction from streamlined processes Learn More If a Sponsor is interested in learning more about Accelero, where should I direct them? Please reach out to the SCRI Business Development team at David.Adler@SCRI.com. SCRI's Scaled Seamless Operations Model to Accelerate Drug Development